We are excited to introduce Bluefield Innovations – a collaboration, with a soon to be announced healthcare venture partner, designed to de-risk the development of early stage therapeutics.
Bluefield Innovations will provide up to $65 million in initial funding over five years to support the commercialization of early stage therapeutic research at Johns Hopkins, with additional funding available to advance research showing strong commercial potential.
Please join us for an informational session and Q&A to learn more about this exciting new collaboration!
Space is limited. Register now!
Thursday, November 16, 2017
3:00 p.m. – 5:00 p.m.